Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia

Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors are a new class of anti-anemia agents. We retrospectively evaluated the safety and efficacy of HIF-PH inhibitors in patients with heart failure (...

Source: BMC Research Notes - March 1, 2024 Category: Research Authors: Takahiro Kambara, Rei Shibata, Yuusuke Sakamoto, Teruhiro Sakaguchi, Hiroyuki Osanai, Yoshihito Nakashima, Hiroshi Asano, Toyoaki Murohara and Masayoshi Ajioka Tags: Research Note Source Type: research